Edition:
United States

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Opiant Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

29 Oct 2016 Reuters Investment Profile 12 $20.00

Trading Report for (OPNT). A detailed report, including free correlated market analysis, and updates.

Detailed Trading Report for OPNT. Entry levels, target prices, and risk controls are integral. In addition, free market anal...

02 Nov 2016 Stock Traders Daily 5 $20.00

"The Economy Matters" Report for OPNT: the economy's impact on OPNT's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score

"The Economy Matters"(r) Reports feature the powerful Economic Climate Rating and MacroRisk "Stoplight" to help you in your a...

25 Oct 2016 MacroRisk Analytics/EconomicInvestor 8 $25.00

Opiant Pharmaceuticals, Inc. (OPNT) - Financial and Strategic SWOT Analysis Review

Opiant Pharmaceuticals, Inc. (OPNT) - Financial and Strategic SWOT Analysis Review Summary Opiant Pharmaceuticals, Inc. (Opia...

03 Oct 2016 GlobalData 43 $300.00

Wright Investors Service Comprehensive Report for Opiant Pharmaceuticals Inc

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

21 Sep 2016 Wright Reports 63 $75.00

Opiant Pharmaceuticals, Inc. (OPNT) - Financial and Strategic SWOT Analysis Review

Opiant Pharmaceuticals, Inc. (OPNT) - Financial and Strategic SWOT Analysis Review Summary Opiant Pharmaceuticals, Inc. (Opia...

19 Sep 2016 GlobalData 43 $300.00

Opiant Pharmaceuticals, Inc. (OPNT) - Financial and Strategic SWOT Analysis Review

Opiant Pharmaceuticals, Inc. (OPNT) - Financial and Strategic SWOT Analysis Review Summary Opiant Pharmaceuticals, Inc. (Opia...

06 Jun 2016 GlobalData 48 $300.00

Opiant Pharmaceuticals, Inc. (LLTP) - Financial and Strategic SWOT Analysis Review

Opiant Pharmaceuticals, Inc. (LLTP) - Financial and Strategic SWOT Analysis Review Summary Opiant Pharmaceuticals, Inc. (Opia...

07 Mar 2016 GlobalData 46 $300.00

LIGHTLAKE THERAPEUTICS (LLTP=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

05 Mar 2016 Pechala's Reports 2 $25.00

Lightlake Therapeutics Inc. (LLTP) - Financial and Strategic SWOT Analysis Review

Lightlake Therapeutics Inc. (LLTP) - Financial and Strategic SWOT Analysis Review Summary Lightlake Therapeutics Inc. (Lightl...

04 Dec 2015 GlobalData 46 $300.00